Table 1—

Clinical and metabolic variables of subjects in the study

LAGB
No LAGB
BasalAt follow-upBasalAt follow-up
n (M/F)67 (18/49)34 (8/26)
Age (years)42.4 ± 1.0745.6 ± 1.93
BMI (kg/m2)45.1 ± 0.7836.9 ± 0.66*44.7 ± 1.5244.9 ± 1.78
Glucose tolerance (NGT/IGT/diabetes)34/24/960/6/1*18/9/719/6/9
Fasting blood glucose (mmol/l)6.3 ± 0.185.3 ± 0.11*6.3 ± 0.496.2 ± 0.76
Fasting insulin (μU/ml)17.3 ± 1.149.7 ± 0.61*12.9 ± 1.2215.3 ± 1.61
HOMA [(glucose × insulin)/22.5]4.8 ± 0.342.3 ± 0.16*3.6 ± 0.423.7 ± 0.46
HbA1c (%)6.5 ± 0.155.6 ± 0.09*6.7 ± 0.315.9 ± 0.30*
WBCs (no./μl)7,783 ± 2386,909 ± 237*7,635 ± 3137,649 ± 210
  • Data are means ± SE.

  • *

    * Significant versus basal. NGT, normal glucose tolerance.